Editorial Advisory Board

Editor-in-Chief: Ravi B. Parikh, MD, MPP, FACP, is a physician-scientist and expert in AI, digital health, and oncology care delivery. He is a board-certified medical oncologist specializing in genitourinary cancers at Winship Cancer Institute at Emory Midtown. He serves as Associate Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine and as Medical Director of the Winship Data and Technology Applications Shared Resource at Winship Cancer Institute, where he oversees the development and integration of AI applications to improve cancer care.

Dr. Parikh directs the Human-Algorithm Collaboration Lab, an NIH-funded multidisciplinary laboratory that develops and tests algorithm-driven interventions in cancer care and serious illness, with a research portfolio spanning algorithmic bias, explainable AI, wearables, and AI regulation and policy. His work has been published in Science, the New England Journal of Medicine, JAMA, and the Journal of Clinical Oncology. He serves as Associate Editor of the Journal of Clinical Oncology, on the board of the Coalition to Transform Advanced Care, and was a National Academy of Medicine Omenn Fellow, through which he contributed to NAM health and science committees and publications.

Kenneth L. Kehl, MD, MPH, received his MD from the Feinberg School of Medicine at Northwestern University, completed residency in internal medicine at Brigham and Women’s Hospital, and trained in medical oncology at the MD Anderson Cancer Center before joining the faculty in the Lowe Center for Thoracic Oncology and the Division of Population Sciences at Dana-Farber. His research concentrates on developing methods for leveraging observational clinical data to drive cancer research and care delivery, with a particular focus on the role of AI to derive useful insights from electronic health records.

Danielle S. Bitterman, MD, is an Assistant Professor at Harvard Medical School who is dedicated to developing and implementing advances in clinical AI for oncology. She is faculty in the AI in Medicine Program at Mass General Brigham, Clinical Lead for Data Science/AI at Mass General Brigham Digital, and a radiation oncologist at Brigham and Women’s Hospital. Her lab focuses on foundation model evaluation and oversight, computational phenotyping of the electronic health records, and translational studies of AI in the clinic. Dr. Bitterman’s research has been published in high-impact venues spanning medicine and computer science, including Nature Medicine, Lancet Digital Health, the Journal of Clinical Oncology, and NeurIPS. She serves as Associate Editor of JCO Clinical Cancer Informatics and Annals of Oncology.

Travis Zack, MD, PhD, is Chief Medical Officer at OpenEvidence and an Assistant Adjunct Professor at UCSF. His research lies at the intersection of computational biology, clinical medicine, and AI. Travis received his PhD in Biophysics from Harvard and an MD in the Health Sciences and Technology track at MIT and Harvard Medical School. Dr. Zack has dedicated his career to using data-driven approaches to address pressing challenges in medicine. His lab focuses on developing AI models to support clinical decision-making and enhance patient outcomes, including machine learning–based tools for real-world evidence studies and natural language processing methods to extract valuable insights from electronic health records. In his role at OpenEvidence, he oversee design, production, evaluation, and quality for all our existing and future tools for bringing evidence based practice to every clinical decision.

Jame Abraham, MD, FACP, is the Enterprise Chair of the Department of Hematology & Medical Oncology at Cleveland Clinic and a Professor of Medicine at the Cleveland Clinic Lerner College of Medicine. Previously he served as Interim Chair of the Taussig Cancer Institute and Deputy Director of the Case Comprehensive Cancer Center (May 2021–July 2022) and as Director of the Cleveland Clinic Breast Oncology Program and Co-Director of the Comprehensive Breast Cancer Program (2013–2019). Dr. Abraham is a member of the National Comprehensive Cancer Network (NCCN) Breast Cancer Committee as well as of the NRG Breast Cancer Working Group, and he is the Vice Chair of the Research Strategy Committee of NRG Oncology. He is also the Deputy Editor of The ASCO Post and JCO Oncology Practice, and is the founding editor of the Bethesda Handbook of Oncology.